Today: 24 April 2026
Subscribe
Browse Category

NASDAQ:ABBV 30 January 2026 - 31 January 2026

AbbVie stock (ABBV) firms up into earnings week as markets turn cautious

AbbVie stock (ABBV) firms up into earnings week as markets turn cautious

AbbVie shares rose 1.17% to $223.01 Friday, outperforming a broader market dip after Donald Trump nominated Kevin Warsh to lead the Federal Reserve. Trading volume in AbbVie topped its 50-day average ahead of next week’s earnings report. The stock remains about 9% below its 52-week high. AbbVie will release results and hold its earnings call early Wednesday.
31 January 2026
···
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
30 January 2026
···

Stock Market Today

  • Weatherford International Q1 Earnings Beat Estimates on Well Construction Strength
    April 24, 2026, 2:49 PM EDT. Weatherford International (WFRD) reported first-quarter 2026 earnings of $1.49 per share, a 44.7% rise from last year, surpassing estimates by 46.1%. Revenue was $1.15 billion, down 3.4% year-over-year but 1.2% above consensus. The Well Construction and Completions segment held steady at $443 million despite regional operational challenges, contributing to strong earnings. North America revenue fell 12%, while international sales declined 1%, with regional variances including a 17% rise in Europe and drops in Latin America and the Middle East. Adjusted EBITDA declined across key segments due to mixed activity levels and divestitures. Operating income dipped 13% to $123 million, yet net income attributable to Weatherford rose 42% to $108 million, reflecting effective cost management amid geopolitical tensions and market headwinds.

Latest article

StoneCo (STNE) Stock Slides as $2.53 Special Dividend Hits: What Investors Need to Know

StoneCo (STNE) Stock Slides as $2.53 Special Dividend Hits: What Investors Need to Know

24 April 2026
StoneCo shares dropped 16.3% to $12.18 Friday after trading ex-dividend for a $2.53-per-share extraordinary cash payout, totaling about R$3.08 billion. Shareholders approved 2025 accounts and board changes, including naming Mateus Scherer Schwening CEO. The dividend follows the sale of Linx. StoneCo reported 2025 adjusted gross profit up 13.5% to R$6.3 billion and payment volume up 8.7% to R$560.9 billion.
Why Cadence Stock Is Back in Focus Before Earnings as TSMC AI Chip Push Builds

Why Cadence Stock Is Back in Focus Before Earnings as TSMC AI Chip Push Builds

24 April 2026
Cadence shares rose 5.2% to $330.66 Friday, rebounding after a 5.21% drop Thursday. The move followed news that Cadence expanded its AI chip design collaboration with TSMC, covering advanced process nodes. Investors await Cadence’s first-quarter earnings report Monday. Rosenblatt reiterated a Buy rating and set a $360 price target.
TSMC Stock Hits Record After Taiwan Opens the Buying Door for Funds

TSMC Stock Hits Record After Taiwan Opens the Buying Door for Funds

24 April 2026
TSMC shares closed at a record NT$2,185 in Taipei Friday, up 5.05%, after Taiwan eased single-stock limits for local equity funds and active ETFs. The rule change allows these funds to invest up to 25% in companies like TSMC, which makes up over 40% of the market. TSMC also announced a new A13 chip roadmap and expanded U.S. packaging plans. MediaTek and UniMicron shares also rose sharply.
Go toTop